Eltrog Eltrombopag 25mg Tablets 7's
Manufacturer: GLENMARK PHARMACEUTICALS LTD
Salt: ELTROMBOPAG 25MG
Category: Anemia
Price: $11
Availability: In Stock
Eltrog 25mg Tablet are an anticoagulant drug belonging to the thrombopoietin (TPO) receptor agonist category, containing the active ingredient Eltrombopag. It treats low platelet counts caused by primary immune thrombocytopenia (ITP) or hepatitis C (HCV) infection. ITP refers to an autoimmune disorder in which the immune system destroys platelets. Platelets are blood cells that aid in clotting and protect blood vessel walls. When platelet levels are low, it can result in severe bleeding and bruising. This tablet is also used in adults to treat low blood counts caused by severe aplastic anemia (a serious blood disease that occurs when the bone marrow fails to produce enough new blood cells).
This drug should not be used in individuals with known hypersensitivity or allergic reactions to the drug or its components. Allergic reactions can range from mild to severe and may include symptoms such as rash, itching, swelling, dizziness, or difficulty breathing. Eltrog 25mg Tablet is contraindicated in patients with severe liver impairment or active liver disease. This drug can potentially cause hepatotoxicity, as indicated by increased liver enzymes and bilirubin levels. Using this drug in individuals with severe liver disease can further worsen liver function, so caution is advised. Your doctor will recommend that you are checked for cataracts. Your doctor should arrange regular testing if you do not have routine eye tests. You may also be checked for bleeding in or around your retina (the light-sensitive layer of cells at the back of the eye).
If you stop taking this tablet, your blood platelet count is likely to become low again within several days. The platelet count will be monitored, and your doctor will discuss appropriate precautions. A very high blood platelet count may increase the risk of blood clotting. However, blood clots can also form with normal or even low platelet counts. Your doctor will adjust your dose of this medicine to ensure that your platelet count does not become too high. Do not take this tablet with dairy products or drinks, as the calcium in these items affects the absorption of the medicine. Use effective birth control during the treatment, and if you become pregnant, you must inform your doctor. Eltrog 25mg Tablet is not advised for children aged under one who has ITP. It is also not recommended for patients under 18 with low platelet counts caused by hepatitis C or severe aplastic anemia. Tell your doctor if you are taking, have recently taken, or might take other medicines. It includes medicines obtained without a prescription and vitamins.
Low platelet counts are caused by primary immune thrombocytopenia (ITP) or hepatitis C virus (HCV) infection.
Severe aplastic anemia.
Eltrog Eltrombopag 25mg Tablets 7's
Product Information
What is Eltrog Eltrombopag 25mg Tablets 7's?
Eltrog 25mg Tablet are an anticoagulant drug belonging to the thrombopoietin (TPO) receptor agonist category, containing the active ingredient Eltrombopag. It treats low platelet counts caused by primary immune thrombocytopenia (ITP) or hepatitis C (HCV) infection. ITP refers to an autoimmune disorder in which the immune system destroys platelets. Platelets are blood cells that aid in clotting and protect blood vessel walls. When platelet levels are low, it can result in severe bleeding and bruising. This tablet is also used in adults to treat low blood counts caused by severe aplastic anemia (a serious blood disease that occurs when the bone marrow fails to produce enough new blood cells).
This drug should not be used in individuals with known hypersensitivity or allergic reactions to the drug or its components. Allergic reactions can range from mild to severe and may include symptoms such as rash, itching, swelling, dizziness, or difficulty breathing. Eltrog 25mg Tablet is contraindicated in patients with severe liver impairment or active liver disease. This drug can potentially cause hepatotoxicity, as indicated by increased liver enzymes and bilirubin levels. Using this drug in individuals with severe liver disease can further worsen liver function, so caution is advised. Your doctor will recommend that you are checked for cataracts. Your doctor should arrange regular testing if you do not have routine eye tests. You may also be checked for bleeding in or around your retina (the light-sensitive layer of cells at the back of the eye).
If you stop taking this tablet, your blood platelet count is likely to become low again within several days. The platelet count will be monitored, and your doctor will discuss appropriate precautions. A very high blood platelet count may increase the risk of blood clotting. However, blood clots can also form with normal or even low platelet counts. Your doctor will adjust your dose of this medicine to ensure that your platelet count does not become too high. Do not take this tablet with dairy products or drinks, as the calcium in these items affects the absorption of the medicine. Use effective birth control during the treatment, and if you become pregnant, you must inform your doctor. Eltrog 25mg Tablet is not advised for children aged under one who has ITP. It is also not recommended for patients under 18 with low platelet counts caused by hepatitis C or severe aplastic anemia. Tell your doctor if you are taking, have recently taken, or might take other medicines. It includes medicines obtained without a prescription and vitamins.
Indications for Eltrog Eltrombopag 25mg Tablets 7's
Low platelet counts are caused by primary immune thrombocytopenia (ITP) or hepatitis C virus (HCV) infection.
Severe aplastic anemia.
Therapeutic Effects of Eltrog Eltrombopag 25mg Tablets 7's
Eltrog 25mg Tablet stimulates megakaryocytes (the large bone marrow cells) responsible for producing platelets. By raising the number of platelets in the blood, this drug prevents bleeding and bruising.
How to consume Eltrog Eltrombopag 25mg Tablets 7's
It is an orally available prescription drug. Your doctor will decide the dose and duration of the drug based on the disease condition and other factors. Always take an Eltrog 25mg Tablet as prescribed by your doctor. Take the tablet with or without food. Do not chew, crush, or break the tablet. Swallow the whole tablet with water.
Side Effects of Eltrog Eltrombopag 25mg Tablets 7's
Nausea
Diarrhea, abdominal pain
Common cold
Cough
Respiratory tract infection
Back pain
High temperature, cough
Loss of appetite
Hair loss
Swelling in feet or hands
Headache, dizziness
Mouth and throat pain
Joint pain
Drug Interactions
Inform your healthcare provider about your medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products. Certain medications include antacid medicines, statins, ciclosporin, methotrexate, topotecan, lopinavir, or ritonavir, and vitamin and mineral supplements may interact with Eltrog 25mg Tablet and reduce effectiveness by causing undesirable side effects.
Storage & Handling
Store Eltrog 25mg Tablet at room temperature (25°C).
Keep the medicine out of reach of children and pets.
Expert Advice
Ensure that in the 2 hours after or 4 hours before you take this medication, you don’t consume dairy foods (such as cheese or butter), milk or milkshakes, antacids, and supplements containing iron, aluminum, magnesium, calcium, selenium, zinc, or calcium. If you forget to take Eltrog 25mg Tablet, take your next dose at the usual time. Do not take more than one dose of this drug daily. Don’t stop taking this tablet without talking to your doctor. If your doctor advises you to stop treatment, your platelet count will be checked each week for four weeks. If you have any doubts regarding the use of this medicine, ask your doctor.
Worldwide Shipping & Delivery
We provide specialized tracked delivery for Eltrog Eltrombopag 25mg Tablets 7's to multiple countries across the globe. Our logistics network ensures temperature-controlled handling for sensitive oncology medications.
- USA Shipping
- UK Delivery
- UAE & Middle East
- Germany & EU
- Australia
- Canada
Professional Safety Guidelines for Eltrog Eltrombopag 25mg Tablets 7's

Pregnancy
UnsafeEltrog 25mg Tablet is not recommended for pregnant patients because it may cause fetal harm. You must inform your doctor if you are pregnant, suspecting, or planning to get pregnant during the treatment.

BreastFeeding
Consult your doctorIt is not known whether Eltrog 25mg Tablet passes into breast milk. If you are breastfeeding or planning to breastfeed, tell your doctor.

Liver
Consult your doctorEltrog 25mg Tablet should be cautiously administered in patients with severe liver diseases. Dose adjustments are necessary for severe liver failure. Inform your doctor if you have liver issues before initiating the therapy.

Lungs
Consult your doctorIt is unknown whether Eltrog 25mg Tablet can be prescribed for patients with lung problems. Consult your doctor if you have any lung diseases before starting the treatment.

Alcohol
Consult your doctorIt is unknown whether alcohol may interact with the Eltrog 25mg Tablet. Inform your physician if you drink alcoholic beverages.

Driving
UnsafeDriving vehicles or operating heavy machinery is unsafe after taking the Eltrog 25mg Tablet. It may cause dizziness and impair concentration.